Global Cardiovascular and Soft Tissue Repair Patches Market to Reach $8.3 Billion by 2030
The global market for Cardiovascular and Soft Tissue Repair Patches estimated at US$4.4 Billion in the year 2022, is projected to reach a revised size of US$8.3 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2022-2030. ePTFE, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biomaterial & Tissue Engineered Material segment is readjusted to a revised 8.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 13.4% CAGR
The Cardiovascular and Soft Tissue Repair Patches market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2030 trailing a CAGR of 13.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.Select Competitors (Total 42 Featured) -
- Abbott (St Jude Medical)
- Admedus
- Atriummed
- B.Braun
- Bard Peripheral Vascular, Inc.
- Baxter
- CorMatrix
- Cryolife, Inc.
- Edwards Life Sciences Corporation
- GETINGE Group
- Glycar SA Pty Ltd.
- Gunze Limited
- LabCor
- LeMaitre Vascular Inc.
- Maverick Bioscience
- Medtronic
- Neovasc
- Novomedics
- Perouse Medical
- Southern Lights Biomaterials
- TEI Biosciences Inc.
- Terumo Medical Corporation
- W.L. Gore & Associates, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott (St Jude Medical)
- Admedus
- Atriummed
- B.Braun
- Bard Peripheral Vascular, Inc.
- Baxter
- CorMatrix
- Cryolife, Inc.
- Edwards Life Sciences Corporation
- GETINGE Group
- Glycar SA Pty Ltd.
- Gunze Limited
- LabCor
- LeMaitre Vascular Inc.
- Maverick Bioscience
- Medtronic
- Neovasc
- Novomedics
- Perouse Medical
- Southern Lights Biomaterials
- TEI Biosciences Inc.
- Terumo Medical Corporation
- W.L. Gore & Associates, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 93 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.4 Billion |
Forecasted Market Value ( USD | $ 8.3 Billion |
Compound Annual Growth Rate | 8.3% |
Regions Covered | Global |